Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (241-250 of 752) with videos related to

Pageof 76
Sort By:
International Journal of Cardiology|February 7, 2012
Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirinJolanta M Siller-Matula, Georg Delle-Karth, Günter Christ, et al.
Wiener Klinische Wochenschrift|March 22, 2014
Effects of AV-delay optimization on hemodynamic parameters in patients with VDD pacemakersKonstantin A Krychtiuk, Michael Nürnberg, Romana Volker, et al.
Thrombosis Research|April 18, 2006
Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarctionWalter Stefan Speidl, Mariam Nikfardjam, Alexander Niessner, et al.
International Journal of Endocrinology|April 27, 2012
Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot StudySerdar Farhan, Ammon Handisurya, Jelena Todoric, et al.
Shock (Augusta, Ga.)|May 31, 2018
Intestinal Fatty Acid Binding Protein is Associated With Mortality in Patients With Acute Heart Failure or Cardiogenic ShockStefan P Kastl, Konstantin A Krychtiuk, Max Lenz, et al.
European Journal of Clinical Investigation|June 8, 2019
Course of platelet miRNAs after cessation of P2Y12 antagonistsBernhard Jäger, Stefan Stojkovic, Paul M Haller, et al.
JACC. Cardiovascular Interventions|October 24, 2009
The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary interventionAllan M Ross, Kurt Huber, Uwe Zeymer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004
Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty: predictive value for a complicated course?Alexander Niessner, Stephan Hornykewycz, Senta Graf, et al.
European Heart Journal. Acute Cardiovascular Care|December 28, 2017
How is cardiac troponin released from injured myocardium?Johannes Mair, Bertil Lindahl, Ola Hammarsten, et al.
Thrombosis Research|June 19, 2008
Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantationKatharina M Katsaros, Stefan P Kastl, Kurt Huber, et al.
Pageof 76

Showing results (241-250 of 752) with videos related to

Sort By:
Pageof 76
International Journal of Cardiology|February 7, 2012
Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirinJolanta M Siller-Matula, Georg Delle-Karth, Günter Christ, et al.
Wiener Klinische Wochenschrift|March 22, 2014
Effects of AV-delay optimization on hemodynamic parameters in patients with VDD pacemakersKonstantin A Krychtiuk, Michael Nürnberg, Romana Volker, et al.
Thrombosis Research|April 18, 2006
Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarctionWalter Stefan Speidl, Mariam Nikfardjam, Alexander Niessner, et al.
International Journal of Endocrinology|April 27, 2012
Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot StudySerdar Farhan, Ammon Handisurya, Jelena Todoric, et al.
Shock (Augusta, Ga.)|May 31, 2018
Intestinal Fatty Acid Binding Protein is Associated With Mortality in Patients With Acute Heart Failure or Cardiogenic ShockStefan P Kastl, Konstantin A Krychtiuk, Max Lenz, et al.
European Journal of Clinical Investigation|June 8, 2019
Course of platelet miRNAs after cessation of P2Y12 antagonistsBernhard Jäger, Stefan Stojkovic, Paul M Haller, et al.
JACC. Cardiovascular Interventions|October 24, 2009
The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary interventionAllan M Ross, Kurt Huber, Uwe Zeymer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004
Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty: predictive value for a complicated course?Alexander Niessner, Stephan Hornykewycz, Senta Graf, et al.
European Heart Journal. Acute Cardiovascular Care|December 28, 2017
How is cardiac troponin released from injured myocardium?Johannes Mair, Bertil Lindahl, Ola Hammarsten, et al.
Thrombosis Research|June 19, 2008
Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantationKatharina M Katsaros, Stefan P Kastl, Kurt Huber, et al.
Pageof 76